SEC Form 4 · accession 0001104659-17-073184
Astrana Health, Inc. · ASTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
NNA OF NEVADA INC
Other
Period of report
Dec 8, 2017
Accepted (ET)
Dec 13, 2017 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001083446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF1 | holding | — | — | — | 800,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is an indirect, wholly-owned subsidiary of Fresesnius Medical Care Holdings, Inc. ("FMCH"). FMCH is an indirect wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA. Mr. Mark Fawcett, Senior Vice President and Treasurer of the Reporting Person and of FMCH, currently serves as a director of the Issuer.
Remarks
Names and addresses of additional Reporting Persons: 1. Fresenius Medical Care Holdings, Inc., 920 Winter Street, Waltham MA, 02451-1547. 2. Fresenius Medical Care & Co. KGaA, Else-Kroner Strasse 1, 61352 Bad Homburg, Germany.